Cookie Settings

We use cookies to optimize our website. These include cookies that are necessary for the operation of the site, as well as those that are only used for anonymous statistic. You can decide for yourself which categories you want to allow. Further information can be found in our data privacy protection .


These cookies are necessary to run the core functionalities of this website and cannot be disabled.

Name Webedition CMS
Purpose This cookie is required by the CMS (Content Management System) Webedition for the system to function correctly. Typically, this cookie is deleted when the browser is closed.
Name econda
Purpose Session cookie emos_jcsid for the web analysis software econda. This runs in the “anonymized measurement” mode. There is no personal reference. As soon as the user leaves the site, tracking is ended and all data in the browser are automatically deleted.

These cookies help us understand how visitors interact with our website by collecting and analyzing information anonymously. Depending on the tool, one or more cookies are set by the provider.

Name econda
Purpose Statistics
External media

Content from external media platforms is blocked by default. If cookies from external media are accepted, access to this content no longer requires manual consent.

Name YouTube
Purpose Show YouTube content
Name Twitter
Purpose activate Twitter Feeds


Team Leader: Martin Schäfer

The "Radiopharmaceuticals" working group of the "Radiopharmaceuticals and Preclinical Studies" sevice unit is focusing on the development and optimization of radiopharmaceuticals for preclinical application in nuclear medicine. Our expertise includes the synthesis of peptidic and peptidomimetic ligands, conjugation and labelling chemistry as well as the development of radiochemical separation techniques of medically relevant radionuclides. Our goal is thus, on the one hand, the development and optimization of novel radiopharmaceuticals and, on the other hand, the optimisation of radiochemical processes for nuclear medicine applications.


Dipl.-Ing. (FH) Martin Schäfer

Service Unit for Radiopharmaceuticals and Preclinical Studies
Im Neuenheimer Feld 223
69120 Heidelberg, Germany

Tel.: +49-6221-42-3554
E-Mail: martin.schaefer (at)

to top
powered by webEdition CMS